This is particularly relevant for the long-acting weekly formulations, where minor variations in absorption rate would have minimal impact on overall therapeutic effect
Qi X, Ng KT, Lian Q, Li CX, Geng W, Ling CC, Yeung WH, Ma YY, Liu XB, Liu H, et al
Bottom line Orforglipron is a next-generation oral GLP-1 that could help many people reach and maintain their health goals, particularly in terms of weight and blood sugar
Multiple clinical trials studying over a dozen therapies failed to show improvement in visual outcomes for NAION patients, with surgical interventions showing no benefit and potentially causing harm
In these studies, the weight loss medication remained the same, but the hormonal status was different